Trials / Completed
CompletedNCT04541316
Neo-angiogenesis in Inguinal Henia Implant ProFlor
Neo-angiogenesis in 3D Dynamic Responsive Implant for Inguinal Hernia Repair ProFlor
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 15 (actual)
- Sponsor
- University of Cagliari · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
The investigation is aimed at specifically demonstrating the ingrowth of newly formed vascular elements within ProFlor, a 3D dynamic responsive implant for inguinal hernia repair
Detailed description
Biopsy specimen were excised at defined postoperative stages from patients who underwent hernia repair with the 3D prosthesis named ProFlor. Scope of the study was to determine the presence, quantity and quality of the vascular elements ingrowth within the implant fabric. Histology revealed the presence of multiple angiogenetic clusters that, starting from the early stage post-implantation, increased in number and degree of maturation. In the long term, the detected vascular components assumed the typical aspect of mature veins and arteries complete in all components. The development of fully developed vascular structures, ingrowing together with other components of the abdominal wall already described in literature, seems to finalize a regenerative response. This kind of behavior, being the expected result from a device intended for the cure of inguinal hernia and its degenerative source, seems to be coherent with the pathogenesis of the disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ProFlor inguinal hernia device | Inguinal hernia repair |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2020-01-01
- Completion
- 2020-07-01
- First posted
- 2020-09-09
- Last updated
- 2020-09-10
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04541316. Inclusion in this directory is not an endorsement.